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Cardiomyopathies are common, seemingly monogenic
autosomal dominant cardiac disorders known as the pri-
mary cause of sudden cardiac death in young adults.
These diseases are characterized by a remarkable genetic
heterogeneity, which makes it difficult to unravel the
causative mutation in a diagnostic laboratory that is very
laborious and expensive by Sanger sequencing.
To circumvent these limitations, we explored solutions
of high throughput sequencing of targeted exomes with
the aim to implement this approach in routine diagnos-
tics. As a first test we designed a capture microarray
with the total genomic length of 1 Mbp that includes all
exons/splicing sites of 130 genes involved in cardiovas-
cular mendelian disorders and analyzed simultaneously
four samples by multiplexing patients with cardiomyo-
pathies or Long-QT syndrome. Pathogenic mutations
and variants of unknown significance were found thus
resolving the genetic causes of the cardiopathy in three.
In the fourth patient the mutation usually associated
with hypertrophic cardiomyopathy was found with
Long-QT. Further developments to next generation
diagnostics are now in progress, and will be also
discussed.
In conclusion, high throughput sequencing holds con-
siderable promises for molecular diagnosis of highly het-
erogeneous disorders in clinical practice and allows a
better understanding of the complexity of mendelian
disorders.
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